Press releaseACCESS Newswire
Petros Pharmaceuticals
PTPI · NASDAQ
$0.0028−$0.0001 (−3.45%)TodayMarket closed ·
Prev close $0.0029
Latest news
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseACCESS Newswire
Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Why Toll Brothers Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releaseACCESS Newswire
Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releaseACCESS Newswire
Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform
- News
Petros Pharmaceuticals Develops Licensable AI-Enabled SaaS Platform To Help Industry Comply With Trump's MAHA Executive Order By Facilitating FDA-Guided Rx-To-OTC Drug Approvals Through A Smart Health Tech System
- Press releaseACCESS Newswire
Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsAvi Kapoor
US Stocks Mixed; Coca-Cola Posts Upbeat Earnings
- Press releaseACCESS Newswire
Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Press releaseACCESS Newswire
Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications
- Press releaseACCESS Newswire
Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study
- NewsAvi Kapoor
Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings
- NewsAvi Kapoor
US Stocks Mixed; NY State Business Activity Rises In February
- Press releaseACCESSWIRE
Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules
- NewsAvi Kapoor
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Why Mitek Systems Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.